Latest news with #POI
Kuwait Times
19-05-2025
- General
- Kuwait Times
IMA ladies wing, Pearls of Islam, celebrates annual day
IMA ladies wing, Pearls of Islam, celebrates annual day 'The definition of true beauty is an amalgamation of knowledge, confidence and character' said Amina Tamimi—Daiya, Ministry of Islamic Affairs- while addressing the audience as the guest speaker on the occasion of Pear of Islam (POI), annual day celebration in Salmiya, Kuwait. She motivated and inspired young girls on how a varied knowledge in respect to their lives and true beauty can be achieved and obtained by working on one's inner self. The event continued with a mesmerizing Nasheed by the young POI students followed by speech on Waqf and its importance in Islam by MariyamAfroz, a member, IMA-LW who explained in detail about this act. Through her speech and a presentation, the speaker made the audience aware about the Waqf amendment 2025 and its implications on the Muslim and Indian Society as a whole and how important is to play our required roles and responsibilities at this crucial moment in order to make the people aware about it. An interesting quiz session was also conducted covering the main topic of the event and its importance filling the hall with enthusiasm and excitement. Rewards and consolation prizes were given to the participants including both the teachers and the students from IMA POI. The event witnessed 65 girls and approximately 35 ladies who attended the program which came to an end by a vote of thanks to all the teachers, students and volunteers who worked hard behind the stage and the entire audience without whom the event would not have been such a success. IMA POI is a subsidiary unit of IMA Ladies Wing, active among the young girls in Kuwait. Only with few girl students a journey started back in 2016 in different parts of Kuwait, is now playing an impactful role in bringing out the best and hidden talents of the society and shaping these young minds to understand and stand firm with respect to their faith and morals in order to become a responsible one in the society. Congratulations to all participants, and the entire IMA POI team! May Allah accept their effort, guide us towards continued success, and keep them steadfast in serving their goal with sincerity and excellence. Aameen! IMA Ladies Wing, mother umbrella of POI is a part of IMA Kuwait, playing an active role by providing a platform to the ladies and young girls mostly belonging to the Indian diaspora in Kuwait by inculcating the Islamic Spirit among the Muslim Ladies in Indian diaspora in Kuwait since day one of its existence. Indian Muslim Organization (IMA) Kuwait is a prominent Indian socio-religious organization operating under the patronage of the Ministry of Islamic Affairs, Kuwait, continues to serve expatriates by organizing events that enhance their spiritual and social well-being. It looks forward to hosting more impactful programs in the future, catering to the needs of the Indian expatriate community in Kuwait.
Yahoo
04-04-2025
- Business
- Yahoo
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive Agreement with Predictive Oncology Predictive Oncology, Inc. (NASDAQ: POAI) to initiate the previously announced integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States. Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. ('POI') dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 (collectively, the 'Binding Agreements'). On April 3, 2025, Renovaro received an email from POI terminating the merger transaction. Renovaro's position is that POI must comply with the binding obligations thereunder and enter into an exclusive License Agreement as required in each of the Binding Agreements. Renovaro notes that POI is in breach of the Binding Agreements and has caused substantial damage to Renovaro for which it will seek redress. Failure to enter into an exclusive License Agreement on the terms set forth in the Binding Agreement on or before April 10, 2025, will cause Renovaro to seek all its legal remedies to recover all its damages and/or seek additional remedies to fully redress the breaches. About Renovaro Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development. For more information, visit Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as 'believes,' 'plans,' 'expects,' 'aims,' 'intends,' 'potential,' or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro's most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. Investor RelationsChris TysonExecutive Vice PresidentMZ Group - MZ North America949-491-8235RENB@ For media inquiries, please contact:karen@
Associated Press
04-04-2025
- Business
- Associated Press
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive Agreement with Predictive Oncology Predictive Oncology, Inc. (NASDAQ: POAI) to initiate the previously announced integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States. Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. ('POI') dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 (collectively, the 'Binding Agreements'). On April 3, 2025, Renovaro received an email from POI terminating the merger transaction. Renovaro's position is that POI must comply with the binding obligations thereunder and enter into an exclusive License Agreement as required in each of the Binding Agreements. Renovaro notes that POI is in breach of the Binding Agreements and has caused substantial damage to Renovaro for which it will seek redress. Failure to enter into an exclusive License Agreement on the terms set forth in the Binding Agreement on or before April 10, 2025, will cause Renovaro to seek all its legal remedies to recover all its damages and/or seek additional remedies to fully redress the breaches. About Renovaro Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development. For more information, visit Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as 'believes,' 'plans,' 'expects,' 'aims,' 'intends,' 'potential,' or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro's most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. Chris Tyson 949-491-8235 For media inquiries, please contact:
Gulf News
14-03-2025
- Health
- Gulf News
Navigate menopause with knowledge and support
Anita S. (name changed), 46, an HR manager in Dubai, found herself irritable at work, waking up drenched in sweat, and struggling to focus on routine tasks. 'At first, I thought it was stress,' she recalls. 'I was working long hours, juggling home and work. But the brain fog, irregular periods, and hot flashes worsened.' When a friend suggested it might be perimenopause, Anita was surprised. 'Menopause was something I associated with women in their 50s, not mid-40s!' Anita's experience is far from unique. Perimenopause — the transitional phase before menopause — can begin in a woman's early 40s and last for several years. Yet, many women remain unaware of its symptoms and potential health risks. Dubai-based Dr Usha Kiran, Consultant Gynaecologist at Prime Hospital, explains: 'Perimenopause can be confusing because women may still have periods but experience mood swings, irritability, hot flashes, and fatigue. This gradual decline in ovarian function is nature's way of preparing the body. But without proper awareness and support, it can significantly impact a woman's quality of life.' For some women, the process can happen even earlier — before the age of 40 — a condition known as Premature Menopause or Premature Ovarian Insufficiency (POI). Dr Nahla Kazim, Director of Fertility Preservation at Bournhall Mediclinic Fertility Centre and founder, Kazim's Fertility Barza, highlights the importance of early diagnosis. 'POI affects about 1 per cent of women globally and can result from genetic conditions, autoimmune disorders, cancer treatments, or unknown causes. Its symptoms mirror natural menopause but come with amplified long-term health risks such as osteoporosis, cardiovascular disease, and neurological changes,' she says. Understanding the symptoms Menopause isn't a sudden event but a gradual transition. Women often mistake early signs for lifestyle-related stress or aging. Common symptoms include: ■ Hot flashes and night sweats ■ Mood swings and irritability ■ Brain fog and memory lapses ■ Joint pain and weight gain 'These symptoms may appear several years before menstruation ceases,' explains Dr Usha. 'It's crucial for women to recognise them and seek medical advice early to manage the changes effectively.' There are two main reasons to treat menopause: symptom management and long-term health. 'Symptoms like hot flashes and mood swings usually improve within two to five years. However, the long-term effects of menopause, such as bone loss (osteoporosis), increased risk of heart disease, and cognitive decline, require attention. Hormone replacement therapy (HRT) is highly effective in preventing these issues. While diet and exercise can help, they are not as effective as HRT in maintaining bone, heart, and brain health,' says Dr Usha. That said, not all women require treatment for menopause. 'If a woman has no symptoms, she may not need intervention beyond advice on maintaining bone and muscle health through exercise, calcium, and vitamin D,' says Dr Usha. Managing premature menopause For women experiencing premature menopause, the stakes are higher. The loss of reproductive potential and the health risks can be devastating without early intervention. Dr Nahla emphasises the importance of fertility preservation. 'Egg freezing is a game-changer for women diagnosed with conditions that could lead to early ovarian failure. Ideally, women should consult a fertility specialist before age 35 for best outcomes. Advances in vitrification techniques have improved success rates.' Emerging therapies are offering new hope to women with premature menopause. Dr Nahla sheds light on cutting-edge treatments like in vitro activation (IVA), stem cell therapy, and intra-ovarian platelet-rich plasma (PRP) administration. 'These therapies are still investigational but show promising results.' As science continues to evolve, the key to managing menopause. 'Women should be empowered to talk about these changes openly,' says Dr Usha. 'No woman should feel like she has to endure these symptoms in silence.' Both Dr Usha and Dr Nahla emphasise the need for a proactive approach. 'Talk to your doctor, stay informed, and seek support,' urges Dr Nahla. 'Menopause is a natural phase of life, but with the right guidance, women can navigate it with strength and confidence.' Anita, into her perimenopausal journey, couldn't agree more. 'Once I understood what was happening, everything became easier to manage. I'm learning to listen to my body, seek help when I need it, and take things one day at a time.' Ayurveda and menopause Menopause is a significant life transition, yet for many women, it remains a phase fraught with confusion, discomfort, and societal silence. While modern medicine offers solutions like hormone replacement therapy (HRT), traditional systems like Ayurveda provide a holistic, time-tested approach that helps women navigate this change with balance and grace. 'Ayurveda views menopause as a natural evolution — one that can be managed effectively through diet, lifestyle, and herbal interventions,' says Dr Anjali Devi, Ayurveda Functional Medicine Practitioner at Dr Anjali's Ayurvedic Center, Karama, Dubai. She offers some tips: Ayurveda categorises life into different phases governed by the three doshas — Vata, Pitta, and Kapha. The menopausal transition, which includes perimenopause, menopause, and postmenopause, is primarily influenced by Vata and Pitta imbalances. As estrogen levels decline, the body's ability to retain moisture, maintain bone density, and regulate temperature is affected, leading to symptoms like hot flashes and mood swings. Ayurveda's approach is centred around restoring this equilibrium. By focusing on Dina Charya (daily routine), Ahara (nutrition), and Rasayana Chikitsa (rejuvenation therapies), Ayurveda helps women maintain vitality. Managing symptoms naturally Hot Flashes and Night Sweats: Excess Pitta contributes to heat imbalances. Cooling foods like cucumber, melons, and pomegranate, along with hydrating herbal teas infused with fennel and coriander, can help. Avoiding spicy foods is also crucial. Mood swings and anxiety: Vata imbalance can lead to mental restlessness. Abhyanga (self-massage) with warm sesame oil calms the nervous system. Sleep disturbances: A nightly cup of warm milk infused with nutmeg and turmeric acts as a natural sleep aid. Practicing mindfulness and listening to theta wave music can enhance relaxation. Bone and joint health: With oestrogen depletion, bone density declines. Rasayana therapies, combined with calcium-rich foods like sesame seeds, figs, and leafy greens, support bone health.
Yahoo
12-03-2025
- Health
- Yahoo
Federal judge rules in favor of drugmaker in HPV vaccine case
A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil. The rest of the case is still going on. 2022: Local women sue Merck after allegedly suffering side-effects from HPV vaccine Some patients claim the drugmaker rushed the vaccine to market, hid serious side effects, and exaggerated the vaccine's effectiveness.. The court said Gardasil is 'remarkably effective,' the vaccine 'has prevented innumerable deaths,' and 'no scientist could reasonably conclude there is a causal association between POTS and POI and Gardasil based on this paucity of evidence.' You may recall that Charlotte has been the epicenter of this major national legal battle. Merck emailed Action 9, 'The evidence that Gardasil does not cause POTS and its associated symptoms or POI is consistent and overwhelming. It includes data from the manufacturer's clinical trials in tens of thousands of people, data from independent, real-world epidemiological studies conducted in hundreds of thousands of people, and worldwide consensus of medical, scientific, and regulatory bodies that have reviewed all the available scientific evidence to date.' VIDEO: Action 9: Local women sue Merck after allegedly suffering side-effects from HPV vaccine
